Testosterone metabolism was studied in tissues associated with a keratin-filled cutaneous cyst. Instead of the 5\g=a\-reducedmetabolites usually associated with skin steroid metabolism, considerable amounts of 5\g=b\-reducedsteroids were found. These included 5\g=b\-androstane\x=req-\ 3,17-dione, 17\g=b\-hydroxy-5\g=b\-androstan-3-one, and 5\g=b\-androstane-3\g=b\,17\g=b\-diol. This change in metabolic pattern is discussed.
INTRODUCTION
Studies of androgen metabolism in target organs have indicated that 5a-dihydrotestosterone may be the active form of testosterone (Bruchovsky & Wilson, 1968) . 5a-Dihydrotestosterone is formed from testosterone in skin and may be important in controlling the growth of androgen-sensitive structures in this organ (Wilson & Walker, 1969) . Localized excess formation of 5a-dihydrotestosteione in the skin may be involved in androgen-dependent diseases such as acne vulgaris and idiopathic hirsutism (Milne, 1969; Hay & Hodgins, 1974) . This paper reports an investigation of testosterone metabolism in tissue associated with a keratin-filled cutaneous cyst. The cyst, a sphere about 1 cm in diameter, was composed of concentric layers of keratin situated between the lower dermis and the subcutaneous muscle. It has been postulated that these keratin-filled cysts arise from the inclusion of epidermal material in the dermis (Pinkus & Mehregan, 1969) . This study was carried out because when first received this cyst was thought to be a ' sebaceous ' cyst, the study of which might have a bearing on acne. The results obtained are reported because they are not those usually expected for testosterone metabolism of human skin and muscle.
The following trivial names have been used in the text: 5a-androstanedione, 5a-androstane-3,17-dione; 5/?-androstanedione, 5/?-androstane-3,17-dione; 5a-dihydrotestosterone, 17/#-hydroxy-5a-androstan-3-one; 5/i-dihydrotestosterone, 17/?-hydroxy-5/?-androstan-3-one; epiandrosterone, 3/?-hydroxy-5a-androstan-17-one.
MATERIALS AND METHODS

Tissues
All tissues were frozen on solid C02 at the time of biopsy and then stored in sealed con¬ tainers at -25°C for up to 1 week before use. The Purification, identification and estimation of steroids The extraction of steroids, removal of lipids and separation of neutral steroids and steroid conjugate fractions were carried out as described previously (Chakraborty, Thomson, MacSween, Muir, Calman, Grant & Milne, 1970) . The procedures for thin-layer and paper chromatography have been described by Hodgins (1971) and . The following steroids were separated from each other by thin-layer and paper chromato¬ graphy using the sequence of solvents described by Hodgins (1971) : androstenedione, 5a-androstanedione, 5/?-androstanedione, androsterone, epiandrosterone, aetiocholanolone, 5a-dihydrotestosterone, testosterone, an androstanediol fraction and a polar neutral fraction.
Samples were removed from each purified steroid fraction for the estimation of radio¬ activity and of carrier recovery as described by Chakraborty et al. (1970) . The radiochemical purity of each steroid was determined by crystallization to constant specific activity with authentic carrier (10 mg); the crystals were weighed on a Cahn Electrobalance (Cahn Instrument Co., Paramount, California, U.S.A.).
Isolation of Sß-steroids from incubations of the cyst and its associated tissues The steroid 5/?-androstanedione can be separated from the other carrier steroids by the sequence of solvents used here (Hodgins, 1971) . The final step in this procedure involves separation from 5a-androstanedione by t.l.c. on silica gel using the solvent cyclohexene:cyclohexanone (9:1, v/v).
It was found during this investigation that the radioactivity in the epiandrosterone fractions did not co-crystallize with added epiandrosterone carrier. Similarly the radio¬ activity in the aetiocholanolone fractions derived from incubations of the cyst and its associated muscle tissue did not co-crystallize with aetiocholanolone carrier; the aetiocho¬ lanolone fraction derived from the skin incubation did contain aetiocholanolone but this accounted for only 28 Radioactivity was found in only one androstanediol fraction, that from the incubation of the muscle tissue associated with the cyst. Thin-layer and paper chromatography in the solvents described by separated this radioactivity into a fraction migrating with 5/?-androstane-3/?,17/?-diol. After addition of 250 pg each of 5a-androstanedione and 5/?-androstanedione carriers to this fraction, it was oxidized overnight at room temperature with chromic-acetic acid. The recovered radioactivity was identified as 5/?-androstanedione after chromatography in the solvent cyclohexene : cyclohexanone (9:1, v/v) and recrystallization with authentic carrier, confirming the presence of a 5/?-androstanediol in the androstanediol fraction.
RESULTS
The metabolic products obtained on incubating testosterone with the contents of the keratinous cyst and with skin and muscle tissue associated with the cyst are shown in (Hay & Hodgins, 1974) (Rongone, 1966; but only on one occasion have traces of 5/?-androstanedione been isolated .
In man, the 5/?-reduction of A4-3-oxosteroids is considered to take place mainly in the liver and alimentary tract, while 5a-reduction is more characteristic of peripheral tissue, e.g. skin (Mauvais-Jarvis, Bercovici, Crepy & Gauthier, 1970 ). This may not be the case in other species, e.g. Mori, Suzuki & Tamaoki (1974) reported that 5/?-reduction of testos¬ terone occurred in the rooster comb, a tissue which has been extensively studied in relation to the androgenic effects of steroids.
Physiological effects have been reported for a number of 5/?-steroids; aetiocholanolone exerts a pyrogenic effect after administration to man (Kappas, Hellman, Fukushima & Gallagher, 1957) , various 5/?-steroids stimulate porphyrin synthesis in embryonic liver (Granick & Kappas, 1967) and 5/?-dihydrotestosterone inhibits the androgenic effect of 5a-dihydrotestosterone in the rooster comb (Mori et al. 1974) .
In man the 5a : 5ß ratio of urinary steroid metabolites may change markedly in certain diseases, e.g. acute intermittent porphyria, myxoedema (Kappas, Bradlow, Gillette & Gallagher, 1971 ) and lung cancer (Rao, 1972) .
It would be of interest to know whether the 5/?-reduced steroids formed in the tissue surrounding the cyst in this patient played some role in the growth or maintenance of the cyst.
